|
In this issue:
Events
News
Funding Opportunities
Upcoming Events
|
|
Are you an academic entrepreneur or startup focused on developing a novel biomedical technology? Join UC Davis Venture Catalyst and Dr. Stephanie Davis, the National Heart, Lung, and Blood Institute SBIR/STTR Program Coordinator, for a virtual event on Tuesday, October 10, at 1:00 p.m. E.T./10:00 a.m. P.T. to learn about non-dilutive funding through the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs.
Attendees will discover resources to help small businesses advance and commercialize promising technologies for treating, diagnosing, and researching heart, lung, blood, and sleep disorders. They'll also learn how to submit a successful application about upcoming funding opportunities and other specific resources and programs for researchers and entrepreneurs. A short, moderated Q&A session will follow this presentation.
 
Join the Northeastern University Center for Research Innovation on Thursday, November 16, at 9:00 a.m. E.T. for a free webinar held in conjunction with Northeastern University Global Entrepreneurship Week. Attendees will have the opportunity to hear from National Institutes of Health (NIH) program staff members about funding opportunities for academic innovators through the NIH small business (SBIR/STTR) grant programs and other translational research programs.
The following speakers will be presenting at this event:
- Stephanie Davis, Ph.D. (National Heart, Lung, and Blood Institute)
- Kenneth Kim, Ph.D. (National Institute of Allergy and Infectious Diseases)
- LCDR Michael Banyas, M.P.A. (National Institute on Minority Health and Health Disparities)
- Armineh Ghazarian, M.S.F. (National Institute on Aging)
- Vasudev Rao, Ph.D. (National Institute of Mental Health)
- Taryn Aubrecht, Ph.D. (National Institute of Neurological Disorders and Stroke)
- Ian Nova, Ph.D. (National Human Genome Research Institute)
- Meena Rajagopal, Ph.D. (National Center for Advancing Translational Sciences)
- Daniel Gossett, Ph.D. (National Institute of Diabetes Digestive and Kidney Diseases)
Speaker presentations will be followed by a short Q&A session.
|
|
Did you know? I-Corps at NIH is a hands-on entrepreneurship training program designed for Phase I companies that received SBIR or STTR funding from NIH or the CDC.
During eight weeks, you’ll learn how to focus your business plan and where to find the tools you need to help commercialize your product. And there’s no cost to you – a $55,000 supplement covers program costs!
-
Receive training from biotech sector experts
-
Hone your target market by engaging with potential customers
-
Expand your professional network
-
Build the confidence and skills to create a comprehensive business model
This cohort begins in March 2024. The sessions will be held virtually except for the in-person kickoff in Houston, TX, and the in-person closeout session in Bethesda, MD.
Applications for the next cohort are due on Wednesday, November 15, 2023, at 5:00 p.m., your local time.
Small business grantees, are you attending one of the upcoming Company Showcase events like The MedTech Conference or hlth? If so, check out these resources to learn how to perfect your investor pitch, find and build your list of potential investors, and more!
The National Institute of Allergy and Infectious Diseases (NIAID) Small Business Applicant Assistance Program (AAP) is now accepting applications. This program cycle is intended for applicants who plan to submit their Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) grant applications for the January 5, 2024, submission deadline.
The NIAID Small Business AAP will offer support for companies planning to apply for a NIAID Phase I, Phase II/IIB, Fast Track, or Direct-to-Phase II SBIR/STTR awards at no cost. SBIR/STTR contract applications are not eligible to participate in the NIAID AAP. NIAID encourages AAP participation from small businesses that are owned or operated by individuals who are traditionally underrepresented in biomedical sciences, such as women-owned small businesses, socially/economically disadvantaged small businesses, and companies located within Historically Under-utilized Business (HUB) Zones.
If you meet the eligibility requirements and are interested in the AAP, we suggest applying as soon as possible. Participation is limited to the first 35 qualified applicants. Only one AAP application is allowed from each company for each AAP cycle.
When the SBIR, STTR, and related pilot programs were reauthorized for FY2023-2025, the SBIR and STTR Extension Act of 2022 made several changes to the SBIR and STTR programs. Policy changes were announced June 12 through this Notice: Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-award and Post-Award Requirements (NOT-OD-23-139).
Key elements include:
- disclosure requirements regarding ties to foreign countries,
- a requirement for federal agencies that manage SBIR and STTR programs to establish a due diligence program to assess security risks posed by applicants, and
- denial of award and recovery authority provisions when ties to foreign countries of concern pose a significant risk.
This policy applies to all NIH, CDC, FDA, and ACL competing applications for SBIR or STTR funding on or after September 5, 2023. More information and resources will be provided in the near future.
|
|
|
The NIH Small Business Program is accepting applications for SBIR & STTR funding. Learn more about these open opportunities.
Learn how to apply and what to do if you encounter systems issues.
Next receipt date: Friday, January 5, 2024.
The FY24 SBIR contract solicitation has been released.
The solicitation lists specific need areas (referred to as Contract Topics). To submit a contract proposal, your small business must respond to one of these topics.
View the solicitation (PHS-2024-1) and learn about the differences between grants and contracts.
Proposals are due by Tuesday, Nov. 14, 2023, at 05:00 p.m. EDT.
The deadline to apply for the NIA Research and Entrepreneurial Development Immersion (REDI) Program is quickly approaching. The program provides bio-entrepreneurship training to boost the number of university startups and facilitate more diverse career opportunities for early-career scientists working in the fields of aging and aging-related diseases.
-
PAR-22-226: The REDI Entrepreneurship Enhancement Award (R25) is designed to broaden the skills of graduate students, postdocs, and early-career recent graduates in fields relevant to healthy aging and Alzheimer’s disease research.
Application Deadline: Wednesday, October 18, 2023.
-
PAR-22-227: The REDI Mentored Entrepreneurial Career Development Award fosters the transition to research independence by providing support and protected time over three to five years for intensive, supervised career development in biomedical, behavioral, or clinical sciences in research areas supported by NIA.
Application Deadline: Wednesday, October 18, 2023.
-
RFA-AG-24-042 and RFA-AG-24-043: The REDI Entrepreneurial Small Business Transition Awards foster career development among scientists with an interest in entrepreneurial training and mentorship while supporting the development of their small business and facilitating their transition from academia to industry.
Application Deadline: Thursday, October 26, 2023.
|
|
|
|
|
